Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Joe D, Strain"'
Publikováno v:
Risk Management and Healthcare Policy, Vol 2010, Iss default, Pp 1-11 (2009)
James R Clem1, Joe D Strain2, Debra K Farver31South Dakota State University College of Pharmacy Sioux Falls, South Dakota, USA; 2South Dakota State University College of Pharmacy, Rapid City Regional Hospital, Rapid City, South Dakota, USA; 3South Da
Externí odkaz:
https://doaj.org/article/fab347ffb5f542f6b78cc31781ecc8d3
Publikováno v:
Drug Design, Development and Therapy, Vol 2009, Iss default, Pp 131-142 (2009)
Michael D Lemon1, Joe D Strain2, Annie M Hegg1, Debra K Farver3 1Department of Pharmacy Practice, South Dakota State University College of Pharmacy, VA Black Hills Health Care System, Fort Meade, SD, USA; 2Department of Pharmacy Practice, South Dakot
Externí odkaz:
https://doaj.org/article/6078dd431dee4352acfd4069ccf660de
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 5, Pp 949-964 (2008)
Dennis D Hedge, Joe D Strain, Jodi R Heins, Debra K FarverSouth Dakota State University College of Pharmacy, Brookings, SD 57007, USAAbstract: Clostridium difficile infections (CDI) have increased in frequency throughout the world. In addition to an
Externí odkaz:
https://doaj.org/article/4e89e9c79b614328818305ccab07781c
Publikováno v:
INNOVATIONS in Pharmacy, Vol 5, Iss 3 (2014)
Objective: To describe a longitudinal leadership program involving all students and report the perceived impact. Design: The program included a first year Leadership Interview, a third year Report of Leadership, and a fourth year Professional Busi
Externí odkaz:
https://doaj.org/article/0d7753f1052642a28cc1ecbf1e2936ae
Publikováno v:
Journal of clinical pharmacology. 57(7)
Brivaracetam is an analogue of levetiracetam that is Food and Drug Administration-approved for adjunctive treatment of partial-onset seizures in patients 16 years and older. In placebo-controlled trials adjunct brivaracetam demonstrated efficacy in r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9e817741c5a7a39c77e70304a60f72e5
https://pubmed.ncbi.nlm.nih.gov/28394442
https://pubmed.ncbi.nlm.nih.gov/28394442
Publikováno v:
Risk Management and Healthcare Policy
Risk Management and Healthcare Policy, Vol 2010, Iss default, Pp 1-11 (2009)
Risk Management and Healthcare Policy, Vol 2010, Iss default, Pp 1-11 (2009)
James R Clem1, Joe D Strain2, Debra K Farver31South Dakota State University College of Pharmacy Sioux Falls, South Dakota, USA; 2South Dakota State University College of Pharmacy, Rapid City Regional Hospital, Rapid City, South Dakota, USA; 3South Da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e489626cf24b29db41fad4f411fcfc5
http://europepmc.org/articles/PMC3270916
http://europepmc.org/articles/PMC3270916
Publikováno v:
Therapeutics and Clinical Risk Management. 4:949-964
Clostridium difficile infections (CDI) have increased in frequency throughout the world. In addition to an increase in frequency, recent CDI epidemics have been linked to a hypervirulent C. difficile strain resulting in greater severity of disease. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33f2af5d462a510badfb5321e3ec6f8f
https://doi.org/10.2147/tcrm.s3145
https://doi.org/10.2147/tcrm.s3145
Publikováno v:
American Journal of Health-System Pharmacy. 70:1876-1878
Agreements between colleges of pharmacy and affiliated practice sites allow faculty members to provide contemporary clinical pharmacy service while educating pharmacy students during pharmacy practice experiences.[1][1] Assessment of the faculty memb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca70d9f2d7d5a4fc7551b77c6437769
https://doi.org/10.2146/ajhp120462
https://doi.org/10.2146/ajhp120462
Publikováno v:
INNOVATIONS in Pharmacy, Vol 5, Iss 3 (2014)
Objective: To describe a longitudinal leadership program involving all students and report the perceived impact. Design: The program included a first year Leadership Interview, a third year Report of Leadership, and a fourth year Professional Busines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03ec2a70f3739178837f7b1dcb147a31
https://doi.org/10.24926/iip.v5i3.349
https://doi.org/10.24926/iip.v5i3.349
Publikováno v:
Therapeutics and Clinical Risk Management
Clostridium difficile infections (CDI) have increased in frequency throughout the world. In addition to an increase in frequency, recent CDI epidemics have been linked to a hypervirulent C. difficile strain resulting in greater severity of disease. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ba93546dfa8e0c70781cac79807aab5
https://pubmed.ncbi.nlm.nih.gov/19209277
https://pubmed.ncbi.nlm.nih.gov/19209277